ImageneBio, Inc. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
ImageneBio, Inc. (IMA) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $11.90 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-05-07
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $11.90M.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $10.90M.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $7.50M.
- 2025-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.80M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2026-03-31 | $11.90M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $10.90M 10-K · filed 2026-03-10 |
| 2025-09-30 | $7.50M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.80M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $2.30M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $3.90M 10-K · filed 2025-03-06 |
| 2024-09-30 | $4.90M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $7.10M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $8.50M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $11.20M 10-K · filed 2024-03-12 |
| 2023-09-30 | $13.40M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $15.90M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $17.80M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $17.70M 10-K · filed 2023-03-14 |
| 2022-09-30 | $22.00M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $22.00M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $22.50M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $19.10M 10-K · filed 2022-03-17 |
| 2021-09-30 | $17.10M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $15.50M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $14.40M 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |